7028-67-3

Usage

Uses

Used in Pharmaceutical Industry:
3-(4-METHYLTHIOBENZOYL)PROPIONIC ACID serves as an essential intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs, enhancing the therapeutic potential of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(4-METHYLTHIOBENZOYL)PROPIONIC ACID is utilized as an intermediate for the production of agrochemicals. Its role in this industry is crucial for the synthesis of effective and environmentally responsible pesticides and other agricultural chemicals.
Used in Fragrance and Flavoring Industry:
3-(4-METHYLTHIOBENZOYL)PROPIONIC ACID is employed in the creation of fragrances and flavoring agents, capitalizing on its ability to contribute distinct scents and tastes to a variety of products. This makes it a valuable component in the formulation of perfumes, food additives, and other consumer goods.
Used in Material Science:
3-(4-METHYLTHIOBENZOYL)PROPIONIC ACID has potential applications in the development of new materials, where its unique properties can be harnessed to create innovative and improved materials for various applications.
Used in Organic Chemistry Research:
3-(4-METHYLTHIOBENZOYL)PROPIONIC ACID is also utilized in the study of organic chemistry, where it can aid in understanding complex chemical reactions and mechanisms, thus contributing to the broader scientific knowledge base.

InChI:InChI=1/C11H12O3S/c1-15-9-4-2-8(3-5-9)10(12)6-7-11(13)14/h2-5H,6-7H2,1H3,(H,13,14)/p-1

Upstream product

• 108-30-5 succinic acid anhydride 
• 100-68-5 methyl-phenyl-thioether 

Downstream Products

• 116174-33-5 4-(4-methylsulfanyl-phenyl)butyric acid 
• 675609-11-7 (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-(4-thiomethyl)phenylbutanamide 
• 692728-84-0 4-(4-chloro-benzyl)-7-methylsulfanyl-3,4-dihydro-2H-naphthalen-1-one 

Relevant academic research and scientific papers

Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3

Naphthalenic analogs of MCA-NAT (5-methoxycarbonylamino-N-acetyltryptamine) have been synthesized and evaluated as melatonin receptor ligands. Introduction of a methoxycarbonylamino substituent at the C-7 position of the naphthalenic nucleus yields MTsub

A simple procedure for the isolation of γ-oxobenzenebutanoic acid derivatives: Application to the synthesis of fenbufen

A simple, convenient, and industrially viable process for the isolation of 4-oxobutanoic acid derivatives resulting from Friedel-Crafts acylation products of aromatic hydrocarbons with succinic anhydride is reported. The isolation procedure involves simple quenching of the reaction mixture followed by filtration of the product in good yield and with excellent purity. The generality of the procedure has been demonstrated with representative examples of aromatic hydrocarbon precursors and has also been applied to the isolation of fenbufen. The quantity of aluminum chloride used in the reaction has also been optimized to reduce the load on effluent.

OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPERATION AND THEIR USE AS ANTIMYCOBACTERIAL AGENTS

Novel compounds belonging to the class of oxazolidinones possessing potent antimycobacterial properties especially useful in the treatment of acid fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium-intracellular complex, M. fortuitum and M. kansai. The compound and its pharmaceutically acceptable salts thereof act as antibacterial agents. Also disclosed is a method for inhibiting growth of mycobacterial cells a well as a method of treating mycobacterial conditions such as Mycobacterium tuberculoses, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellular complex, M. fortuitum and M. kansai, comprising administering an antimycobacterially effective amount of the said compound and/or pharmaceutically acceptable salts thereof. There is also disclosed a process for the manufacture of the said compound or its pharmaceutically acceptable salts.